首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Borrelidin Induces the Unfolded Protein Response inOral Cancer Cells and Chop-Dependent Apoptosis
【2h】

Borrelidin Induces the Unfolded Protein Response inOral Cancer Cells and Chop-Dependent Apoptosis

机译:硼瑞林诱导未折叠的蛋白反应口腔癌细胞与切碎依赖性细胞凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oral squamous cell carcinoma (OSCC) is the most common cancer affecting the oral cavity, and US clinics will register about 30,000 new patients in 2015. Current treatment modalities include chemotherapy, surgery, and radiotherapy, which often result in astonishing disfigurement. Cancers of the head and neck display enhanced levels of glucose-regulated proteins and translation initiation factors associated with endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). Previous work demonstrated that chemically enforced UPR could overwhelm these adaptive features and selectively kill malignant cells. The threonyl-tRNA synthetase (ThRS) inhibitor borrelidin and two congeners were discovered in a cell-based chemical genomic screen. Borrelidin increased XBP1 splicing and led to accumulation of phosphorylated eIF2α and UPR-associated genes, prior to death in panel of OSCC cells. Murine embryonic fibroblasts (MEFs) null for GCN2 and PERK were less able to accumulate UPR markers and were resistant to borrelidin. This study demonstrates that UPR induction is a feature of ThRS inhibition and adds to a growing body of literature suggesting ThRS inhibitorsmight selectively target cancer cells.
机译:口腔鳞状细胞癌(OSCC)是影响口腔的最常见癌症,美国诊所将在2015年注册约30,000名新患者。目前的治疗方式包括化学疗法,手术和放射疗法,这通常会导致令人惊讶的毁容。头颈癌显示出与内质网(ER)应激和未折叠的蛋白反应(UPR)相关的葡萄糖调节蛋白和翻译起始因子水平提高。先前的工作表明,化学强化的UPR可能会使这些适应性特征不堪重负,并有选择地杀死恶性细胞。在基于细胞的化学基因组筛选中发现了苏氨酰tRNA合成酶(ThRS)抑制剂硼瑞林和两个同类物。在OSCC细胞死亡之前,硼瑞林增加XBP1剪接并导致磷酸化的eIF2α和UPR相关基因的积累。 GCN2和PERK无效的小鼠胚胎成纤维细胞(MEF)积累UPR标记的能力较弱,并且对硼瑞丁具有抗性。这项研究表明,UPR诱导是ThRS抑制的特征,并且增加了越来越多的暗示ThRS抑制剂的文献可能选择性地靶向癌细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号